Details for Patent: 11,618,748
✉ Email this page to a colleague
Which drugs does patent 11,618,748 protect, and when does it expire?
Patent 11,618,748 protects RHOPRESSA and ROCKLATAN and is included in two NDAs.
This patent has thirty patent family members in eight countries.
Drugs Protected by US Patent 11,618,748
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alcon Labs Inc | RHOPRESSA | netarsudil mesylate | SOLUTION/DROPS;OPHTHALMIC | 208254-001 | Dec 18, 2017 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | REDUCTION OF ELEVATED INTRAOCULAR PRESSURE | ⤷ Try a Trial | ||||
Alcon Labs Inc | ROCKLATAN | latanoprost; netarsudil dimesylate | SOLUTION/DROPS;OPHTHALMIC | 208259-001 | Mar 12, 2019 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | REDUCTION OF ELEVATED INTRAOCULAR PRESSURE | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,618,748
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2010241996 | ⤷ Try a Trial | |||
Australia | 2010242800 | ⤷ Try a Trial | |||
Australia | 2016201754 | ⤷ Try a Trial | |||
Australia | 2017248440 | ⤷ Try a Trial | |||
Australia | 2019210632 | ⤷ Try a Trial | |||
Australia | 2021204320 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |